Back to
GABELLI FUNDS LLC
VERV2 quarters
Position history for
GABELLI FUNDS LLC's holdings in VERVE THERAPEUTICS INC
As of its Q2 2025 13F, Gabelli Funds held 267,520 shares of VERV (Verve Therapeutics), worth $3M.
Final Value
$0
Final Shares
0
Total Value Change
-$3M
Total Shares Change
-267,520
Quarter-by-Quarter History
Other major holders of VERV: Alphabet Inc., FMR LLC